메뉴 건너뛰기
Nephrology Dialysis Transplantation
Volumn 23, Issue 7, 2008, Pages 2436-2438
Metformin-associated lactic acidosis in type 2 diabetes mellitus: Incidence and presentation in common clinical practice
Author keywords

[No Author keywords available]
Indexed keywords

CREATININE; METFORMIN;
EID: 46849098978     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn152     Document Type: Letter
Times cited : (33)
References (7)
  • 1
    • 0032511566 scopus 로고    scopus 로고
    • Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS)
    • UK Prospective Diabetes Study (UKPDS) Group
    • UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS). Lancet 1998; 352: 854-865
    • (1998) Lancet , vol.352 , pp. 854-865
  • 2
    • 33746588255 scopus 로고    scopus 로고
    • Management of hyperglycemia in Type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
    • Nathan DM, Buse JB, Davidson MB et al. Management of hyperglycemia in Type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006; 29: 1963-1972
    • (2006) Diabetes Care , vol.29 , pp. 1963-1972
    • Nathan, D.M.1    Buse, J.B.2    Davidson, M.B.3
  • 3
    • 33645516747 scopus 로고    scopus 로고
    • Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
    • CD002967
    • Salpeter S, Greyber E, Pasternak G et al. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 2006; CD002967
    • (2006) Cochrane Database Syst Rev
    • Salpeter, S.1    Greyber, E.2    Pasternak, G.3
  • 4
    • 24044478791 scopus 로고    scopus 로고
    • Metformin's contraindications should be contraindicated
    • McCormack J, Johns K, Tildesley H. Metformin's contraindications should be contraindicated. CMAJ 2005; 173: 502-504
    • (2005) CMAJ , vol.173 , pp. 502-504
    • McCormack, J.1    Johns, K.2    Tildesley, H.3
  • 5
    • 0020677309 scopus 로고
    • The status of metformin in Canada
    • Lucis OJ. The status of metformin in Canada. Can Med Assoc J 1983; 128: 24-26
    • (1983) Can Med Assoc J , vol.128 , pp. 24-26
    • Lucis, O.J.1
  • 6
    • 0034901899 scopus 로고    scopus 로고
    • Contraindications to metformin therapy in patients with Type 2 diabetes - a population-based study of adherence to prescribing guidelines
    • Emslie-Smith AM, Boyle DI, Evans JM et al. Contraindications to metformin therapy in patients with Type 2 diabetes - a population-based study of adherence to prescribing guidelines. Diabet Med 2001; 18: 483-488
    • (2001) Diabet Med , vol.18 , pp. 483-488
    • Emslie-Smith, A.M.1    Boyle, D.I.2    Evans, J.M.3
  • 7
    • 25844485486 scopus 로고    scopus 로고
    • Fulminant lactic acidosis in two patients with Type 2 diabetes treated with metformin
    • Brassoe R, Elkmann T, Hempel M et al. Fulminant lactic acidosis in two patients with Type 2 diabetes treated with metformin. Diabet Med 2005; 22: 1451-1453
    • (2005) Diabet Med , vol.22 , pp. 1451-1453
    • Brassoe, R.1    Elkmann, T.2    Hempel, M.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.